"Από την ίδρυσή του το 2001, το Metropolitan Hospital καθιερώθηκε σε υψηλή θέση στον κλάδο της ιδιωτικής υγείας. 1.500 ιατροί υψηλού επιστημονικού κύρους και 800 άρτια εκπαιδευμένοι νοσηλευτές, 35.000 ασθενείς για νοσηλεία, 350.000 επισκέπτες κάθε χρόνο στα εξωτερικά ιατρεία, υπερσύγχρονες εγκαταστάσεις, προηγμένος τεχνολογικός εξοπλισμός και συνεργασίες με διεθνή επιστημονικά κέντρα τοποθετούν το Μetropolitan μεταξύ των καλύτερων θεραπευτηρίων της Ευρώπης, με συνεχείς επιτυχίες στην έρευνα και στην εφαρμογή πρωτοποριακών μεθόδων διάγνωσης και θεραπείας. Tο Metropolitan Hospital πρώτο θεραπευτήριο στην Ελλάδα και το τέταρτο παγκοσμίως που απέκτησε την πιστοποίηση EXCELLENCE IN MEDICAL TOURISM του TEMOS Ιnternational."

During the past decade, Metropolitan Hospital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 10 clinical trials were completed, i.e. on average, 34.5% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 7 clinical trials were completed. i.e. 41.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metropolitan Hospital" #1 sponsor was "Amgen" with 8 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Hellenic Cooperative Oncology Group" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metropolitan Hospital" #1 collaborator was "University of Athens" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Docobo Ltd." with 1 trials as a collaborator and "European Cancer Patient Coalition (ECPC)" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Metropolitan Hospital" are "Melanoma" (7 trials), "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Non Small Cell Lung Cancer" (3 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Metropolitan Hospital" in a lesser frequency.

Most popular intervention types in "Metropolitan Hospital" are "Drug" (24 trials), "Biological" (5 trials), "Other" (4 trials), "Diagnostic Test" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Cisplatin" (3 trials), "Gemcitabine" (3 trials), "Atezolizumab" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Metropolitan Hospital" are 33 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Metropolitan Hospital". undefined are not yet recruiting, 11 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Metropolitan Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Metropolitan Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Metropolitan Hospital has several departments that took part in Clinical trials: "2nd Dept of Medical Oncology, Metropolitan Hospital" - 16 trials, "Metropolitan Hospital; 2Nd Oncology Clinic" - 6 trials, "Metropolitan Hospital; Hematology Dept" - 2 trials